Insider Transactions in Q1 2024 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-4.48%
|
$1,440,000
$72.51 P/Share
|
|
Mar 15
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.06%
|
$380,000
$19.12 P/Share
|
|
Mar 15
2024
|
Raju Prasad Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,524
-35.24%
|
$253,728
$72.69 P/Share
|
|
Mar 14
2024
|
Raju Prasad Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Mar 12
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,583
-2.15%
|
$339,142
$74.44 P/Share
|
|
Mar 12
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,146
-1.84%
|
$84,804
$74.44 P/Share
|
|
Mar 11
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+4.06%
|
-
|
|
Mar 11
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,802
-4.59%
|
$764,556
$78.26 P/Share
|
|
Mar 11
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+3.48%
|
-
|
|
Mar 11
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,801
-4.46%
|
$218,478
$78.26 P/Share
|
|
Mar 10
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,250
+8.27%
|
-
|
|
Mar 10
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+8.04%
|
-
|
|
Feb 27
2024
|
Simeon George |
BUY
Grant, award, or other acquisition
|
Indirect |
1,048,951
+50.0%
|
$74,475,521
$71.5 P/Share
|
|
Feb 20
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,370
-3.18%
|
$503,230
$79.67 P/Share
|
|
Feb 20
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,913
-3.23%
|
$151,127
$79.67 P/Share
|
|
Feb 18
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,250
+6.2%
|
-
|
|
Feb 18
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+6.06%
|
-
|
|
Feb 15
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-3.3%
|
$1,600,000
$80.88 P/Share
|
|
Feb 15
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.8%
|
$380,000
$19.12 P/Share
|
|
Jan 29
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-10.57%
|
$3,000,000
$60.8 P/Share
|
|
Jan 29
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.4%
|
$950,000
$19.12 P/Share
|
|
Jan 16
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-9.64%
|
$1,240,000
$62.5 P/Share
|
|
Jan 16
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.8%
|
$380,000
$19.12 P/Share
|